Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1830-1835, 2005. First published August 11, 2005; 10.1373/clinchem.2005.053595
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.053595v1
51/10/1830    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snyder, J. A.
Right arrow Articles by Grenache, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snyder, J. A.
Right arrow Articles by Grenache, D. G.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2005;51:1830-1835.)
© 2005 American Association for Clinical Chemistry, Inc.

Endocrinology and Metabolism

Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging Women

Jennifer A. Snyder1,1, Shannon Haymond2,1, Curtis A. Parvin2, Ann M. Gronowski2 and David G. Grenache1,a

1 Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC.
2 Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO.

aAddress correspondence to this author at: Department of Pathology and Laboratory Medicine, CB #7525, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC, 27599. Fax 919-966-9490; e-mail dgrenach{at}unch.unc.edu.

Background: Human chorionic gondadotropin (hCG) screening tests are performed on nearly all female patients of childbearing age before any medical intervention. Although older women usually have negative hCG test results, positive results do occur and may cause clinical confusion. We examined changes with age in serum hCG concentrations in nonpregnant women and investigated the use of serum follicle-stimulating hormone (FSH) measurements as an aid to interpreting higher than expected ("positive") hCG results.

Methods: We used 240 serum specimens for each of 4 female cohorts: pregnant, ≥18 years; nonpregnant, 18–40 years (premenopausal); nonpregnant, 41–55 years (perimenopausal); and nonpregnant, >55 years (postmenopausal). Patients were excluded if they had an ectopic pregnancy, a history of trophoblastic disease or a germ-cell tumor, or if no chart was available for review. Quantitative hCG and FSH tests were performed on each specimen.

Results: Serum hCG concentrations in nonpregnant women increased with the age of the women. hCG results were higher and significantly different (P <0.0001) for nonpregnant women >55 years (<2.0 to 13.1 IU/L) compared with nonpregnant women 18–40 years (<2.0 to 4.6 IU/L) and 41–55 years (<2.0 to 7.7 IU/L). Nineteen nonpregnant women >40 years of age had hCG concentrations ≥5.0 IU/L, all with an FSH concentration >32.4 IU/L. The highest FSH concentration in pregnancy was 7.3 IU/L.

Conclusions: Serum hCG increases with age in nonpregnant women. A cutoff of 14.0 IU/L should be used when interpreting hCG results in women >55 years of age. Pregnancy is unlikely in perimenopausal women 41–55 years of age with an hCG between 5.0 and 14.0 IU/L if serum FSH is >20.0 IU/L.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
A. M. Gronowski, C. R. Fantz, C. A. Parvin, L. J. Sokoll, C. L. Wiley, M. H. Wener, and D. G. Grenache
Use of Serum FSH to Identify Perimenopausal Women with Pituitary hCG
Clin. Chem., April 1, 2008; 54(4): 652 - 656.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
U.-H. Stenman
Commentary
Clin. Chem., January 1, 2008; 54(1): 213 - 214.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. R. McCudden, M. S. Willis, and D. G. Grenache
Persistent Low Concentration of Human Chorionic Gonadotropin in a Nonpregnant Woman
Clin. Chem., January 1, 2008; 54(1): 209 - 213.
[Full Text] [PDF]

Home page
 NEJMHome page
L. A. Cole, Y. Sasaki, and C. Y. Muller
Normal Production of Human Chorionic Gonadotropin in Menopause
N. Engl. J. Med., March 15, 2007; 356(11): 1184 - 1186.
[Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu
The classification, functions and clinical use of different isoforms of HCG
Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. A. Cole
"Background" Human Chorionic Gonadotropin in Healthy, Nonpregnant Women
Clin. Chem., October 1, 2005; 51(10): 1765 - 1766.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.